BELX Bio-Pharmaceutical Co. Ltd. participated Bio Taiwan 2017, held at Nan Kang Exhibition Center in June, 2017. The company also made a presentation at the Bio Business Asia Conference 2017 to introduce its current accomplishment and future development plans. This is the first step for the company to step in the international arena.

In companies’ one-on-one partnering discussions, BELX met companies from Asian and European countries, including China, Japan, Korea, Singapore, Australia, Germany, and Hungary. Opportunities in clinical trials and product development were discussed in details to lay a foundation for future collaborations.

BELX will participate more international conferences in the second half of 2017. The goal is to actively seek international investors and collaborators to expedite the company’s growth.